Octo- and nonagenarian donors in lung transplantation: a dual center experience
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F25%3A10493469" target="_blank" >RIV/00064203:_____/25:10493469 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11110/25:10493469
Výsledek na webu
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=V~E0p0Yl3c" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=V~E0p0Yl3c</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.healun.2025.02.002" target="_blank" >10.1016/j.healun.2025.02.002</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Octo- and nonagenarian donors in lung transplantation: a dual center experience
Popis výsledku v původním jazyce
The maximal donor age for lung transplantation (LTx) remains controversial, despite favorable outcomes with donors >=70 years. We report our experience with LTx from donors >=80 years. Donor/recipient characteristics and short-term postoperative outcome were retrospectively analyzed across two centers between 2016 and 2023. Seventeen patients underwent single (n=2) or double (n=15) LTx from octo- or nonagenarian donors with a median age of 83 years (range 80-94). Most donors were non-smoking females with intracerebral bleeding. Last donor PaO(2)/FiO(2) ratio was 440 mmHg. Three recipients developed PGD3 at 72h. Median ICU and hospital stay were 11 and 29 days, respectively. Five patients showed minimal (A1) ACR at one month post-LTx. Two patients developed CLAD. One- and three-year survival rates were 84% and 70%. Our case series indicates that LTx from well-selected octo- and nonagenarian donors is a valuable option to expand the donor pool.
Název v anglickém jazyce
Octo- and nonagenarian donors in lung transplantation: a dual center experience
Popis výsledku anglicky
The maximal donor age for lung transplantation (LTx) remains controversial, despite favorable outcomes with donors >=70 years. We report our experience with LTx from donors >=80 years. Donor/recipient characteristics and short-term postoperative outcome were retrospectively analyzed across two centers between 2016 and 2023. Seventeen patients underwent single (n=2) or double (n=15) LTx from octo- or nonagenarian donors with a median age of 83 years (range 80-94). Most donors were non-smoking females with intracerebral bleeding. Last donor PaO(2)/FiO(2) ratio was 440 mmHg. Three recipients developed PGD3 at 72h. Median ICU and hospital stay were 11 and 29 days, respectively. Five patients showed minimal (A1) ACR at one month post-LTx. Two patients developed CLAD. One- and three-year survival rates were 84% and 70%. Our case series indicates that LTx from well-selected octo- and nonagenarian donors is a valuable option to expand the donor pool.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30212 - Surgery
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2025
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
The Journal of Heart and Lung Transplantation
ISSN
1053-2498
e-ISSN
1557-3117
Svazek periodika
44
Číslo periodika v rámci svazku
5
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
6
Strana od-do
836-841
Kód UT WoS článku
001470058700001
EID výsledku v databázi Scopus
2-s2.0-85219043670